Datos a fecha 30/04/26 16:20
| Ticker | INO |
|---|---|
| ISIN | US45773H4092 |
| Sector | Atención sanitaria |
| Industria | Biotechnology |
| Mercado | NASDAQ |
| Capitalización | $60,020,648 |
| Beta | 1.70 |
| Sitio web | https://www.inovio.com |
| CEO | Jacqueline E. Shea |
| Fecha de IPO | 08/12/1998 |
| País | US |
| Dirección | 660 West Germantown Pike, Plymouth Meeting, PA, 19462 |
| Volumen | 1,035,721 |
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in cond...
El precio actual de Inovio Pharmaceuticals, Inc. (INO) es de 1.12, con una variación del 0.00%.
Inovio Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones